Our use of antibiotics is outpacing the rate at which bacterial pathogens become resistant to the currently available drugs. Meanwhile, the development of new antibiotics is being abandoned by large pharmaceutical companies to small biotech concerns and academic labs. While studying site-specific recombination, we have identified several hexapeptides that inhibit recombination reactions and bind to Holliday junctions, preventing their resolution. We have discovered that these hexapeptides have antimicrobial activity in both gram+ and gram- bacteria, although they are 4-8 fold more potent in gram+ bacteria (including methicillin resistant Staph aureus). Depending on the organism, MICs range from 8-64 mu/g/ml. The antimicrobial activity is associated with chromosome partitioning defects, filamentation, and induction of DNA breaks. Based on confocal microscopy with fluorescently labeled peptides, we have found that the peptides penetrate both gram+ and gram- bacteria. Despite the fact that they are also able to penetrate eukaryotic cells, we have not detected cytotoxic effects in HeLa cells at doses up to 250 mu/g/ml. Our short term goals are to understand the basis of the mechanism of action of these peptides in bacterial cells, to test their antimicrobial activity against intracellular pathogens, and their ability to cure bacterial infections in animal model systems. In addition, we will investigate their activities in different subcellular compartments of eukaryotic cells with an eye towards maximizing their specificity against bacteria and minimizing cytotoxic side effects. Since the peptides may not be optimal for pharmacological use, we are also identifying non-peptide lead compounds that mimic the activity of the peptides.
The specific aims of this study are to: 1) Identify and characterize nonpeptide small molecules that trap Holliday junctions. 2 & 3) Investigate the bacterial targets of the Holliday-junction trapping compounds using a combination of biochemical and genetic approaches. 4) Investigate effects on bacterial membranes. 5) Investigate the effects of Holliday-junction trapping compounds on eukaryotic cells. As part of this specific aim, we will also determine whether the peptides kill intracellular bacteria. 6) Investigate the effect of the peptides on Salmonella and Staph infections in mice in two well-studied infectious disease model systems.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
3R01AI058253-02S1
Application #
7112131
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Alexander, William A
Project Start
2005-09-01
Project End
2006-08-31
Budget Start
2005-09-01
Budget End
2006-05-31
Support Year
2
Fiscal Year
2005
Total Cost
$44,871
Indirect Cost
Name
San Diego State University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
073371346
City
San Diego
State
CA
Country
United States
Zip Code
92182
Lackraj, Tracy; Johnson-Henry, Kathene; Sherman, Philip M et al. (2016) Novel antimicrobial peptide prevents C. rodentium infection in C57BL/6 mice by enhancing acid-induced pathogen killing. Microbiology 162:1641-1650
Kondratova, Anna; Watanabe, Takaaki; Marotta, Michael et al. (2015) Replication fork integrity and intra-S phase checkpoint suppress gene amplification. Nucleic Acids Res 43:2678-90
Rideout, Marc C; Naili, Ilham; Boldt, Jeffrey L et al. (2013) wrwyrggrywrw is a single-chain functional analog of the Holliday junction-binding homodimer, (wrwycr)2. Peptides 40:112-22
Dey, Mamon; Patra, Sukanya; Su, Leo Y et al. (2013) Tumor cell death mediated by peptides that recognize branched intermediates of DNA replication and repair. PLoS One 8:e78751
Orchard, Samantha S; Rostron, Jason E; Segall, Anca M (2012) Escherichia coli enterobactin synthesis and uptake mutants are hypersensitive to an antimicrobial peptide that limits the availability of iron in addition to blocking Holliday junction resolution. Microbiology 158:547-59
Yitzhaki, Shmuel; Rostron, Jason E; Xu, Yan et al. (2012) Similarities between exogenously- and endogenously-induced envelope stress: the effects of a new antibacterial molecule, TPI1609-10. PLoS One 7:e44896
Rideout, Marc C; Boldt, Jeffrey L; Vahi-Ferguson, Gabriel et al. (2011) Potent antimicrobial small molecules screened as inhibitors of tyrosine recombinases and Holliday junction-resolving enzymes. Mol Divers 15:989-1005
Lino, M; Kus, J V; Tran, S L et al. (2011) A novel antimicrobial peptide significantly enhances acid-induced killing of Shiga toxin-producing Escherichia coli O157 and non-O157 serotypes. Microbiology 157:1768-75
Su, Leo Y; Willner, Dana L; Segall, Anca M (2010) An antimicrobial peptide that targets DNA repair intermediates in vitro inhibits Salmonella growth within murine macrophages. Antimicrob Agents Chemother 54:1888-99
Ranjit, Dev K; Rideout, Marc C; Nefzi, Adel et al. (2010) Small molecule functional analogs of peptides that inhibit lambda site-specific recombination and bind Holliday junctions. Bioorg Med Chem Lett 20:4531-4

Showing the most recent 10 out of 15 publications